Provided by Tiger Trade Technology Pte. Ltd.

SPDR NYSE Technology ETF

361.40
+5.231.47%
Post-market: 356.17-5.2300-1.45%19:57 EDT
Volume:22.94K
Turnover:8.26M
Market Cap:1.90B
PE:8.67
High:361.56
Open:358.43
Low:357.78
Close:356.17
52wk High:392.44
52wk Low:239.50
Shares:5.27M
Float Shares:5.27M
Volume Ratio:0.81
T/O Rate:0.44%
Dividend:0.53
Dividend Rate:0.15%
EPS(TTM):41.70
EPS(LYR):41.70
ROE:20.23%
ROA:0.21%
PB:1.68
PE(LYR):8.67

Loading ...

Marvell Posts Q2 Double Beat Driven by Data Center Strength

Benzinga Earnings
·
Aug 28

Marvell Sees Accelerating Growth as AI Demand Boosts 2Q Profit, Revenue

Dow Jones
·
Aug 28

Intel Corp. Stock Rises 4.4%, Underperforms Peers

Dow Jones
·
Aug 28

Applied Materials Adds Qualcomm Executive to Board

TIPRANKS
·
Aug 28

Marvell Stock Falls as Big Expectations Outweigh Solid Earnings

Dow Jones
·
Aug 28

Marvell Q2 Revenue Beat on Data Center Jump Overshadowed by Soft Quarterly Gross Margin Forecast

Reuters
·
Aug 28

Marvell reports Q2 EPS 94c, consensus 93c

TIPRANKS
·
Aug 28

Marvell Q2 FY27 GAAP Diluted EPS Rises to $0.33; Revenue Climbs 37% YoY to $2.74 Billion

Reuters
·
Aug 28

Marvell Technology Shares Down 1.4% After the Bell Following Results

THOMSON REUTERS
·
Aug 28

Marvell Technology Forecasts Quarterly Revenue Above Estimates

Reuters
·
Aug 28

Marvell Tech Q2 Adj. EPS $0.94 Beats $0.92 Estimate, Sales $2.739B Beat $2.710B Estimate

Benzinga Earnings
·
Aug 28

Applied Materials Adds Qualcomm CFO Akash Palkhiwala to Board

Reuters
·
Aug 28

Marvell Technology Q2 Adjusted EPS USD 0.94 Vs. IBES Estimate USD 0.92

Reuters
·
Aug 28

Marvell Technology: We are Seeing Broad-Based Strength Across Our Data Center Portfolio

THOMSON REUTERS
·
Aug 28

Marvell Technology - Q2 Data Center Revenue $2,171.5 Mln

THOMSON REUTERS
·
Aug 28

Marvell Technology: Seeing Significant Acceleration in Our Custom Business Beginning H2 2027

THOMSON REUTERS
·
Aug 28

Marvell Technology Q2 Gross Margin 53.1%

THOMSON REUTERS
·
Aug 28

Marvell Technology Q2 EPS USD 0.33

THOMSON REUTERS
·
Aug 28

Applied Materials Appoints Akash Palkhiwala to Board of Directors

THOMSON REUTERS
·
Aug 28

Outlook Therapeutics Appoints Kevin Lundquist as Chief Financial Officer as It Prepares for U.S. Commercial Launch of LYTENAVA™

GlobeNewswire
·
Aug 28